ID: ALA1161947

Max Phase: Preclinical

Molecular Formula: C15H22O4

Molecular Weight: 266.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCOc1ccc(C(=O)O)cc1OC

Standard InChI:  InChI=1S/C15H22O4/c1-3-4-5-6-7-10-19-13-9-8-12(15(16)17)11-14(13)18-2/h8-9,11H,3-7,10H2,1-2H3,(H,16,17)

Standard InChI Key:  UEVVWVXGDYTQKF-UHFFFAOYSA-N

Associated Targets(non-human)

lpxC UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 266.34Molecular Weight (Monoisotopic): 266.1518AlogP: 3.74#Rotatable Bonds: 9
Polar Surface Area: 55.76Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.14CX Basic pKa: CX LogP: 3.97CX LogD: 0.90
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.69Np Likeness Score: -0.05

References

1. Shin H, Gennadios HA, Whittington DA, Christianson DW..  (2007)  Amphipathic benzoic acid derivatives: synthesis and binding in the hydrophobic tunnel of the zinc deacetylase LpxC.,  15  (7): [PMID:17296300] [10.1016/j.bmc.2007.01.044]

Source